Other grades of this product :
| D-lactosyl-1-1'-N-octanoyl-L-threo-sphingosine Basic information |
| Product Name: | D-lactosyl-1-1'-N-octanoyl-L-threo-sphingosine | | Synonyms: | D-lactosyl-1-1'-N-octanoyl-L-threo-sphingosine;N-[(1S,2S,3E)-1-[[(4-O-beta-D-Galactopyranosyl-beta-D-glucopyranosyl)oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]octanamide;C8 L-THREO-LACTOSYL(Β) CERAMIDE (D18:1/8:0);Lactosyl-b-1,1'-N-octanoyl-L-threo-sphingosine;C8 L-threo-Lactosyl(ss) Ceramide (d18:1/8:0) | | CAS: | 939036-94-9 | | MF: | C38H71NO13 | | MW: | 749.96924 | | EINECS: | | Product Categories: | | Mol File: | 939036-94-9.mol |
| D-lactosyl-1-1'-N-octanoyl-L-threo-sphingosine Chemical Properties |
| D-lactosyl-1-1'-N-octanoyl-L-threo-sphingosine Usage And Synthesis |
| Uses | C8 L-threo-Lactosyl(β) Ceramide (d18:1/8:0) may be used to disrupt brain-derived neurotropic factor (BDNF)-induced integrin clustering. | | General Description | C8 L-threo-Lactosyl(β) Ceramide (d18:1/8:0) is a synthetic glycosphingolipid (GSL) with nonnatural stereochemistry. | | Biochem/physiol Actions | C8 L-threo-Lactosyl(β) Ceramide (d18:1/8:0) is a caveolar uptake inhibitor, which blocks SV40 virus infection. It also prevents E1-integrin activation and downstream signaling. C8 L-threo-Lactosyl(β) Ceramide (d18:1/8:0) can deter the aggregation of lipids and proteins into glycosphingolipids (GSLs) and cholesterol-enriched microdomains (rafts) at the plasma membrane (PM). |
| D-lactosyl-1-1'-N-octanoyl-L-threo-sphingosine Preparation Products And Raw materials |
|
日本语
한국어
Français
Deutsch
España
Türkiye